期刊文献+

Mohnarin 2008年度报告:胸水来源细菌耐药监测 被引量:2

2008 Mohnarin report:Bacterial distribution and resistance of thorax cavity infections
下载PDF
导出
摘要 目的了解我国胸腔感染病原菌的分布及耐药状况。方法采用纸片法、MIC法或E-test法测定病原菌药物敏感性,使用WHONET5.5软件对卫生部全国细菌耐药性监测网(Mohnarin)所属89家三级甲等医院2008年1月1日~2008年12月31日分离的胸水标本菌株进行分析。结果①共有50家医院从胸水标本分离出病原菌共621株,其中革兰阳性菌317株,占51.1%,革兰阴性杆菌304株,占48.9%。②分离量前五位的细菌是金黄色葡萄球菌(11.6%)、大肠埃希菌(9.7%)、铜绿假单胞菌(7.4%)、表皮葡萄球菌(6.8%)、鲍曼不动杆菌和肺炎克雷伯菌(各占5.0%)。③MRSA、MRSCN检出率分别为50%、47.7%;产ESBL大肠埃希菌、肺炎克雷伯菌、产酸克雷伯菌阳性率分别为84.1%、29%、14.3%;未检出VRSA/VISA、未检出VRE。④各菌属耐药状况与全国本年度细菌耐药监测一致。结论我国胸腔感染病原菌最常见为葡萄球菌属;ICU病区以鲍曼不动杆菌和葡萄球菌属比例最高;儿童最常见肺炎链球菌感染;胸水中产ESBL大肠埃希菌检出率高。 Abstract Objective To determine the bacterial distribution and resistant to antibiotic in thorax cavity infections in China. Methods Disc diffusion test, MIC test or E-test were used to detect the antimicrobial sensitivity of bacterial isolates from pleural effusion samples. WHONET 5.5 was applied for analysis of the bacterial sensitive data from 89 tertiary Mohnarin member hospitals at different areas in China from Jan 1, 2008 to Dec 31, 2008. Results @621 organisms from pleural effusion were collected from 50 hospitals in the survey period, which included 317 (51.1%) Gram-positive strains, 304 (48.9%) Gram-negative bacilli. @The top five bacteria were Staphylococcus aureus (11.6%), Escherichia coli(9.7%), Pseudomonas aeruginosa(7.4%), Staphylococcus epdermidis( 6. 7% ), Klebsiella pneumoniae( 5.0% ) and Acinetobacter baumannii (5.0%).@ Methicillin resistant Staphyloccus aureus (MRSA)and coagulase-negative Staphylococcus (MRCNS) accounted for 50% and 47.7% respectively. No Staphylococcus was found resistant or intermediary to vancomycin. No Enterococcus was found resistant to vancomycin. About 84.1% of Escherichia coli and 29% of Klebsiella pneumoniae, 14.3% of Klesiellia oxytoca were ESBL-producing strains. @ Antibiotic resistance in the organisms with the same national antimicrobial resistance monitoring during the year. Conclusions Staphylococcus spp. was the predominant organisms from pleural effusiom the proportion ofA. baumannii and Staphylococcus spp. were more common in intensive care unit (ICU). S. pneumoniaee is the most proportion bacteria in department of pediatrics. The higher positive rate of ESBLsproducing E. coli was found in pleural effusion.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2010年第8期609-613,共5页 Chinese Journal of Antibiotics
关键词 MOHNARIN 胸腔感染 病原菌 耐药性 2008年 Mohnarin Thorax cavity infections Bacteria Antibiotic Resistance 2008
  • 相关文献

参考文献5

二级参考文献26

  • 1李光辉,汪复.重视与加强深部真菌感染的临床研究[J].中国抗感染化疗杂志,2005,5(4):193-194. 被引量:19
  • 2段建春,吕晓菊,赵燕,冯萍,俞汝佳,宗志勇,高燕渝,熊亚莉.产ESBLs肠杆菌科细菌对氨基糖苷类抗生素耐药机制研究[J].中国抗生素杂志,2005,30(9):555-558. 被引量:23
  • 3Cunha BA. Antibiotic resistance[J]. Med Clin North Am, 2008,84(6) : 1407-1430.
  • 4Cunha BA. Pseudomonas aeruginasa : resistance and therapy [J]. Senior Resp Infect, 2002,17(3) : 231-239.
  • 5Scheetz MH, Han KM, Noskia GA. Applying antimicrobial pharmacodynamies to resistant Gram-negative pathogens[J]. Am J Healh Syst Pharm, 2006,63 : 1346-1360.
  • 6Kwti JL, Naghtingale CH, Nicola DP. Optimizing pharmacodynamic, target attainment using the MYSTIC antibiograml data collected in North America in 2002[J].Antimicrob Agents Chemother, 2004,48 : 2464-2470.
  • 7Carmen P O, Rogerio N, Caio M, et al. Multicenter evaluation of resistance patterns of Klebsiella pneumoniae, Escherichia coli , Salmonella spp. and Shigella spp. isolated from clinical specimens in Brazil: RESISTNET Surveillance Program [J]. Brazilian J Infect Dis, 2001,5 (1): 8 -12.
  • 8Su L H, Wu T L, Chia J H, et al. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan [J]. J Antimicrob Chemother, 2005,55 (5) :846 -852.
  • 9Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing, 17 th informational supplement M100-S17. Wayne Pennsylvania: CLSI,2007:100.
  • 10Alvarez M, Tran J H, Chow N, et al. Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States [J]. Antimicrob Agents Chemother, 2004,48(2) : 533- 537.

共引文献115

同被引文献15

  • 1蒋燕群,朱文欣,王坚强,汤瑾.耐碳青霉烯类铜绿假单胞菌耐药机制研究[J].中国感染与化疗杂志,2007,7(1):31-33. 被引量:16
  • 2Davies HE,Davies RJ,Davies CW,et al.Management of pleural infection in adults:British Thoracic Society Pleural Disease Guideline 2010[J].Thorax,2010,65(2):41-53.
  • 3Maskell NA,Batt S,Hedley EL,et al.The bacteriology of pleural infection by genetic and standard methods and its mortality significance[J].Am J Respir Crit Care Med,2006, 174(7):817-823.
  • 4Lisboa T,Waterer GW,Lee YC.Pleural infection:changing bacteriology and its implications[J].Respirology,2011,16(4):598-603.
  • 5Aloush V,Navon-Venezia S,Seigman-Igra Y,et al.Multi- drug resistant Pseudomonas aeruginosa:risk factors and clini- cal impact[J].Antimicrob Agents Chemother,2006,50(1):43-48.
  • 6Hirsch EB,VH Tam.Impact of multidrug-resistant Pseudo- monas aeruginosa infection on patient outcomes[J].Expert Rev Pharmacoecon Outcomes Res*2010,10(4):441-451.
  • 7Hui Li,Yi-Feng Luo,Bryan J. Williams,Timothy S. Blackwell,Can-Mao Xie.Structure and function of OprD protein in Pseudomonas aeruginosa : From antibiotic resistance to novel therapies[J]. International Journal of Medical Microbiology . 2011 (2)
  • 8Yong Dongeun,Lee Kyungwon,Yum Jong Hwa,Shin Hee Bong,Rossolini Gian Maria,Chong Yunsop.Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. Journal of Clinical Microbiology . 2002
  • 9Hirsch Elizabeth B,Tam Vincent H.Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Expert review of pharmacoeconomics & outcomes research . 2010
  • 10Davies Helen E,Davies Robert J O,Davies Christopher W H.Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax . 2010

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部